Skip to content

XENETIC BIOSCIENCES, INC.: 10-Q filed 2013-04-22

What XENETIC BIOSCIENCES, INC. reported in its quarterly report filed 2013-04-22 (fiscal Q2 2013): 23 published measures, 61 facts as tagged in accession 0001255294-13-000285.

This filing

Form
10-Q (quarterly report)
Filed
2013-04-22
Fiscal period
fiscal Q2 2013
Accession
0001255294-13-000285 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All XENETIC BIOSCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-02-28270,738USD
At 2012-08-31324,132USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-02-28363,043USD
At 2012-08-31417,040USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-02-28-92,305USD
At 2012-08-31-92,908USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-09-01 to 2013-02-28603USD181
2011-08-09 to 2013-02-28-137,305USD570
2011-09-01 to 2012-02-29-47,433USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-09-01 to 2013-02-2812,972USD181
2011-08-09 to 2013-02-28-336USD570
2011-09-01 to 2012-02-291,355USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-09-01 to 2013-02-28212,500USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-12-01 to 2013-02-2832,560USD90
2012-09-01 to 2013-02-2865,524USD181
2011-08-09 to 2013-02-28178,310USD570
2011-12-01 to 2012-02-2935,967USD91
2011-09-01 to 2012-02-2949,716USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-08-09 to 2013-02-28257,813USD570

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-08-09 to 2013-02-28-212,500USD570

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-12-01 to 2013-02-28135,000,000shares90
2012-09-01 to 2013-02-28135,000,000shares181
2011-12-01 to 2012-02-29100,000,000shares91
2011-09-01 to 2012-02-29100,000,000shares182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-02-28182,393USD
At 2012-08-31193,019USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-12-01 to 2013-02-2818,245USD90
2012-09-01 to 2013-02-286,962USD181
2011-08-09 to 2013-02-28-117,073USD570
2011-12-01 to 2012-02-29-26,067USD91
2011-09-01 to 2012-02-29-40,885USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-02-2888,345USD
At 2012-08-31131,113USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-12-01 to 2013-02-28-3,162USD90
2012-09-01 to 2013-02-28-6,359USD181
2011-08-09 to 2013-02-28-20,232USD570
2011-12-01 to 2012-02-29-3,197USD91
2011-09-01 to 2012-02-29-6,548USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-02-28150,230USD
At 2012-08-31204,227USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-12-01 to 2013-02-2814,315USD90
2012-09-01 to 2013-02-2858,562USD181
2011-08-09 to 2013-02-28295,383USD570
2011-12-01 to 2012-02-2962,034USD91
2011-09-01 to 2012-02-2990,601USD182

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-02-280USD
At 2012-08-310USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-02-28212,500USD
At 2012-08-31212,500USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-02-2830,107USD
At 2012-08-3119,481USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-09-01 to 2013-02-2810,626USD181
2011-08-09 to 2013-02-2830,107USD570
2011-09-01 to 2012-02-298,855USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-08-09 to 2013-02-2845,000USD570

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-09-01 to 2013-02-2855,740USD181
2011-08-09 to 2013-02-28-43,368USD570
2011-09-01 to 2012-02-29-36,039USD182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-09-01 to 2013-02-28-60,356USD181
2011-08-09 to 2013-02-28130,311USD570
2011-09-01 to 2012-02-2969,424USD182

Inspect the source

Entity
XENETIC BIOSCIENCES, INC. / CIK 0001534525
Captured
2026-09-20T09:16:43.632Z
SEC response SHA-256
0d9d849e14a36c3c398086c2983f13053152bb5ab9dbb765c6ab6226c86b34ff

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001534525.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))